Short-Course Hypofractionated Radiation Therapy With Boost in Women With Stages 0 to IIIa Breast Cancer: A Phase 2 Trial

scientific article published in January 2016

Short-Course Hypofractionated Radiation Therapy With Boost in Women With Stages 0 to IIIa Breast Cancer: A Phase 2 Trial is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.IJROBP.2015.09.011
P698PubMed publication ID26700706

P50authorSharad GoyalQ37830941
Bruce G HafftyQ62127887
Dirk MooreQ89142945
Chunxia ChenQ90653157
Laurie KirsteinQ114739951
Stuti AhlawatQ114739955
P2093author name stringThomas Kearney
Atif J. Khan
P2860cites workEffects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trialsQ29031162
Accelerated hypofractionated radiotherapy as adjuvant regimen after conserving surgery for early breast cancer: interim report of toxicity after a minimum follow up of 3 yearsQ33723980
Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trialsQ34054354
Uptake and costs of hypofractionated vs conventional whole breast irradiation after breast conserving surgery in the United States, 2008-2013.Q34742937
Five-year local control in a phase II study of hypofractionated intensity modulated radiation therapy with an incorporated boost for early stage breast cancerQ36166224
The UK Standardisation of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial.Q36514573
The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trialQ36571627
Four-week course of radiation for breast cancer using hypofractionated intensity modulated radiation therapy with an incorporated boostQ36767280
Phase I-II trial of prone accelerated intensity modulated radiation therapy to the breast to optimally spare normal tissueQ36807209
Overview of the Randomized Trials of Radiotherapy in Ductal Carcinoma In Situ of the BreastQ37509647
Fractionation for whole breast irradiation: an American Society for Radiation Oncology (ASTRO) evidence-based guideline.Q37773606
Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trialQ43427825
Hypofractionated whole breast irradiation for patients with large breasts: a randomized trial comparing prone and supine positionsQ43722411
Five-year results of a prospective case series of accelerated hypofractionated whole breast radiation with concomitant boost to the surgical bed after conserving surgery for early breast cancerQ44057851
Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancerQ44230659
Choosing wisely: the American Society for Radiation Oncology's top 5 list.Q45005764
The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials.Q46425805
A phase 2 trial of once-weekly hypofractionated breast irradiation: first report of acute toxicity, feasibility, and patient satisfactionQ46590180
Long-term results of hypofractionated radiation therapy for breast cancerQ48887913
First results of the randomised UK FAST Trial of radiotherapy hypofractionation for treatment of early breast cancer (CRUKE/04/015).Q53213927
Hypofractionation with simultaneous integrated boost for early breast cancerQ57338044
Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, FranceQ73132146
Dose response and latency for radiation-induced fibrosis, edema, and neuropathy in breast cancer patientsQ77947503
Once-Weekly Hypofractionated Whole-Breast Radiotherapy After Breast-Conserving Surgery in Older Patients: A Potential Alternative Treatment Schedule to Daily 3-Week HypofractionationQ86699248
Hypofractionated radiotherapy for breast cancers--preliminary results from a tertiary care center in eastern IndiaQ95588723
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectadaptive radiation therapyQ180507
phase II clinical trialQ42824440
P304page(s)118-125
P577publication date2016-01-01
P1433published inInternational Journal of Radiation Oncology Biology PhysicsQ2296252
P1476titleShort-Course Hypofractionated Radiation Therapy With Boost in Women With Stages 0 to IIIa Breast Cancer: A Phase 2 Trial
P478volume94

Reverse relations

cites work (P2860)
Q38811255Hypofractionated Postmastectomy Radiation Therapy Is Safe and Effective: First Results From a Prospective Phase II Trial
Q57108643Hypofractionated radiation treatment in the management of breast cancer
Q88262647Normal tissue damage: its importance, history and challenges for the future
Q55362979Predictors of radiation-induced acute skin toxicity in breast cancer at a single institution: Role of fractionation and treatment volume.
Q53980225Relation between Hypofractionated Radiotherapy, Toxicity and Outcome in Early Breast Cancer.

Search more.